Market Closed -
NSE India S.E.
07:43:47 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
1,409
INR
|
+0.21%
|
|
+4.71%
|
+13.07%
|
Fiscal Period: März |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
426,134
|
340,917
|
657,346
|
821,377
|
726,839
|
1,137,701
|
-
|
-
|
Enterprise Value (EV)
1 |
463,108
|
359,042
|
658,708
|
810,334
|
716,397
|
1,081,876
|
1,055,259
|
1,027,456
|
P/E ratio
|
27.9
x
|
22.1
x
|
27.4
x
|
32.7
x
|
26
x
|
27.6
x
|
25.2
x
|
22.6
x
|
Yield
|
0.57%
|
0.71%
|
0.61%
|
0.49%
|
0.94%
|
0.61%
|
0.65%
|
0.72%
|
Capitalization / Revenue
|
2.6
x
|
1.99
x
|
3.43
x
|
3.77
x
|
3.19
x
|
4.41
x
|
4.06
x
|
3.71
x
|
EV / Revenue
|
2.83
x
|
2.1
x
|
3.44
x
|
3.72
x
|
3.15
x
|
4.19
x
|
3.77
x
|
3.35
x
|
EV / EBITDA
|
15
x
|
11.2
x
|
15.5
x
|
17.8
x
|
14.3
x
|
17.2
x
|
15.5
x
|
13.6
x
|
EV / FCF
|
34.8
x
|
14.4
x
|
21.1
x
|
29.1
x
|
29.9
x
|
32.4
x
|
27.4
x
|
23.9
x
|
FCF Yield
|
2.87%
|
6.95%
|
4.74%
|
3.43%
|
3.35%
|
3.09%
|
3.65%
|
4.18%
|
Price to Book
|
2.7
x
|
2.16
x
|
3.59
x
|
3.94
x
|
3.11
x
|
4.26
x
|
3.74
x
|
3.29
x
|
Nbr of stocks (in thousands)
|
805,699
|
806,235
|
806,460
|
806,814
|
807,151
|
807,367
|
-
|
-
|
Reference price
2 |
528.9
|
422.8
|
815.1
|
1,018
|
900.5
|
1,409
|
1,409
|
1,409
|
Announcement Date
|
5/22/19
|
5/15/20
|
5/14/21
|
5/10/22
|
5/12/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
163,624
|
171,320
|
191,596
|
217,633
|
227,531
|
257,973
|
279,909
|
306,971
|
EBITDA
1 |
30,973
|
32,060
|
42,524
|
45,528
|
50,270
|
62,962
|
68,052
|
75,404
|
EBIT
1 |
17,710
|
20,313
|
31,848
|
35,008
|
38,549
|
52,639
|
56,579
|
62,830
|
Operating Margin
|
10.82%
|
11.86%
|
16.62%
|
16.09%
|
16.94%
|
20.4%
|
20.21%
|
20.47%
|
Earnings before Tax (EBT)
1 |
20,791
|
21,782
|
32,901
|
34,933
|
40,384
|
57,277
|
62,394
|
69,672
|
Net income
1 |
15,277
|
15,465
|
24,049
|
25,168
|
28,019
|
41,265
|
44,967
|
50,412
|
Net margin
|
9.34%
|
9.03%
|
12.55%
|
11.56%
|
12.31%
|
16%
|
16.06%
|
16.42%
|
EPS
2 |
18.93
|
19.16
|
29.79
|
31.17
|
34.69
|
51.11
|
55.83
|
62.48
|
Free Cash Flow
1 |
13,311
|
24,957
|
31,255
|
27,818
|
23,971
|
33,440
|
38,487
|
42,964
|
FCF margin
|
8.13%
|
14.57%
|
16.31%
|
12.78%
|
10.54%
|
12.96%
|
13.75%
|
14%
|
FCF Conversion (EBITDA)
|
42.98%
|
77.84%
|
73.5%
|
61.1%
|
47.69%
|
53.11%
|
56.56%
|
56.98%
|
FCF Conversion (Net income)
|
87.13%
|
161.37%
|
129.97%
|
110.53%
|
85.55%
|
81.04%
|
85.59%
|
85.23%
|
Dividend per Share
2 |
3.000
|
3.000
|
5.000
|
5.000
|
8.500
|
8.634
|
9.195
|
10.14
|
Announcement Date
|
5/22/19
|
5/15/20
|
5/14/21
|
5/10/22
|
5/12/23
|
-
|
-
|
-
|
Fiscal Period: März |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
51,687
|
46,064
|
55,044
|
55,198
|
54,789
|
52,603
|
53,752
|
58,285
|
58,101
|
57,393
|
63,289
|
64,681
|
64,992
|
62,574
|
69,303
|
EBITDA
1 |
12,309
|
7,962
|
13,459
|
12,262
|
12,310
|
7,497
|
11,434
|
13,023
|
14,076
|
11,737
|
14,939
|
15,121
|
15,951
|
13,891
|
-
|
EBIT
1 |
9,824
|
5,110
|
10,848
|
9,731
|
9,835
|
4,594
|
8,889
|
10,030
|
11,354
|
8,275
|
12,547
|
12,819
|
13,101
|
11,194
|
13,861
|
Operating Margin
|
19.01%
|
11.09%
|
19.71%
|
17.63%
|
17.95%
|
8.73%
|
16.54%
|
17.21%
|
19.54%
|
14.42%
|
19.82%
|
19.82%
|
20.16%
|
17.89%
|
20%
|
Earnings before Tax (EBT)
1 |
10,215
|
5,437
|
9,955
|
9,958
|
10,541
|
4,478
|
9,746
|
11,004
|
12,181
|
7,454
|
13,746
|
13,757
|
13,933
|
12,446
|
-
|
Net income
1 |
7,482
|
4,134
|
7,147
|
7,114
|
7,286
|
3,621
|
6,864
|
7,889
|
8,010
|
5,256
|
9,957
|
9,743
|
10,517
|
9,088
|
-
|
Net margin
|
14.47%
|
8.97%
|
12.98%
|
12.89%
|
13.3%
|
6.88%
|
12.77%
|
13.54%
|
13.79%
|
9.16%
|
15.73%
|
15.06%
|
16.18%
|
14.52%
|
-
|
EPS
2 |
9.260
|
5.120
|
8.850
|
8.800
|
9.020
|
4.480
|
8.500
|
9.770
|
9.920
|
6.510
|
12.33
|
12.53
|
12.86
|
11.25
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
1/29/21
|
5/14/21
|
8/5/21
|
10/26/21
|
1/25/22
|
5/10/22
|
7/29/22
|
11/4/22
|
1/25/23
|
5/12/23
|
7/26/23
|
-
|
-
|
-
|
-
|
Fiscal Period: März |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
36,974
|
18,125
|
1,363
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
11,043
|
10,443
|
55,826
|
82,442
|
110,245
|
Leverage (Debt/EBITDA)
|
1.194
x
|
0.5654
x
|
0.032
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
13,311
|
24,957
|
31,255
|
27,818
|
23,971
|
33,440
|
38,487
|
42,964
|
ROE (net income / shareholders' equity)
|
10.4%
|
10.1%
|
14.1%
|
12.9%
|
12.7%
|
16.2%
|
15.4%
|
15.2%
|
ROA (Net income/ Total Assets)
|
6.53%
|
6.49%
|
9.85%
|
9.63%
|
9.91%
|
12.7%
|
11.9%
|
12%
|
Assets
1 |
234,120
|
238,129
|
244,072
|
261,266
|
282,821
|
325,660
|
376,671
|
418,648
|
Book Value Per Share
2 |
196.0
|
196.0
|
227.0
|
258.0
|
290.0
|
330.0
|
377.0
|
429.0
|
Cash Flow per Share
2 |
21.00
|
38.00
|
46.50
|
41.20
|
40.10
|
58.40
|
62.70
|
67.70
|
Capex
1 |
3,601
|
5,728
|
6,297
|
5,441
|
11,829
|
10,659
|
10,786
|
10,796
|
Capex / Sales
|
2.2%
|
3.34%
|
3.29%
|
2.5%
|
5.2%
|
4.13%
|
3.85%
|
3.52%
|
Announcement Date
|
5/22/19
|
5/15/20
|
5/14/21
|
5/10/22
|
5/12/23
|
-
|
-
|
-
|
Last Close Price
1,409
INR Average target price
1,453
INR Spread / Average Target +3.10% Consensus |
1st Jan change
|
Capi.
|
---|
| +13.07% | 13.64B | | +19.62% | 43.34B | | +20.44% | 21.96B | | +10.86% | 14.09B | | +37.46% | 11.43B | | -8.59% | 6.86B | | -0.05% | 6.79B | | -8.87% | 5.73B | | +8.46% | 5.22B | | -4.29% | 4.71B |
Generic Pharmaceuticals
|